Plex Pharmaceuticals
Manufacturing · California, United States · <25 Employees
View Company Info for Free
About
Headquarters
6330 Nancy Ridge Dr Ste 105, San Diego, Califor...Phone Number
(858) 587-8800Website
www.plexpharma.comRevenue
<$5 MillionIndustry
Who is Plex Pharmaceuticals
About Plex Pharmaceuticals: Plex Pharmaceuticals, Inc., a subsidiary of Collidion Inc., is an ophthalmology company focused on improving the lives of patients diagnosed with complex degenerative diseases caused by protein misfolding and aggregation. Plex's core competencies are in the discovery of drug-like small molecules by utilizing its core technologies, including functional fragment screening and x-ray crystallography to rationally design and synthesize New Chemical Entities (NCEs). The team at Plex has amassed decades of experience in numerous drug discovery programs that have successfully produced multiple clinical candidates, including an FDA approved drug.Read more
Plex Pharmaceuticals Org Chart
Is Plex Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Plex Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Plex Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Plex Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Plex Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Plex Pharmaceuticals
Plex Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Plex Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Plex Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Plex Pharmaceuticals as Masked Content
Find 3 more new buyers
Similar Companies to Plex Pharmaceuticals
Analyze insights from companies similar to Plex Pharmaceuticals and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- Foldrx Pharmaceuticals<25
$8.9M - MediQuest Therapeuticsundefined$5.2M
- Curemark<25<$5M
- TauRx Pharmaceuticalsundefined$27.1M
- Mimetogen Pharmaceuticalsundefined$5.3M
- OxTheraundefined<$5M
- Patrysundefined<$5M
- AB Scienceundefined<$5M
More similar companies
Plex Pharmaceuticals Employee Growth Rate
View Plex Pharmaceuticals’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
Plex Pharmaceuticals Tech Stack
A closer look at the technologies used by Plex Pharmaceuticals
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Most Recent Scoops
Last Week
Hot Scoop - Business
Last month
Hot Scoop - Financial
Last month
Hot Scoop - Opportunities
Plex Pharmaceuticals News & Media
Plex Pharmaceuticals Awarded $1.6 Million in Grant Funding from NIH to Advance Eye Drop Therapy for Cataracts
SAN DIEGO, July 8, 2020 /PRNewswire/ -- Plex Pharmaceuticals, Inc. ("Plex"), announced that it has been awarded two Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH) National Eye Institute: a $1.3 million Phase II grant (R44EY027236) and a...
Plex Pharmaceuticals Awarded $600,000 Phase I NIH SBIR Grant to Develop Broad-Spectrum Antivirals to Treat Flavivirus Infections
SAN DIEGO, Feb. 4, 2020 /PRNewswire/ -- Plex Pharmaceuticals, Inc. ("Plex"), today announced it has been awarded a $600,000 Phase I Small Business Innovation Research grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to...Plex Pharmaceuticals Announces Positive Ex Vivo Efficacy and Top Line In Vivo Ocular Safety Data of CAP1160
SAN DIEGO, Dec. 3, 2018 /PRNewswire/ -- Plex Pharmaceuticals, Inc. ("Plex" or "the Company"), a preclinical stage biopharmaceutical company focused on developing innovative small molecule therapeutics for protein misfolding and aggregation diseases, today announced positive efficacy...
Read more news
Frequently Asked Questions Regarding Plex Pharmaceuticals
About Plex Pharmaceuticals: Plex Pharmaceuticals, Inc., a subsidiary of Collidion Inc., is an ophthalmology company focused on improving the lives of patients diagnosed with complex degenerative diseases caused by protein misfolding and aggregation. Plex's core competencies are in the discovery of drug-like small molecules by utilizing its core tec... Read More
